Browsen in EconStor gesamt nach Autor:innen von der Schulenburg, Johann-Matthias


Zeige Ergebnisse 1 bis 8 von 8
ErscheinungsjahrTitelAutor:innen
2006Supply and Demand for Terrorism Insurance: Lessons from GermanyThomann, Christian; von der Schulenburg, Johann-Matthias
2008Nutzen und Kosten der derzeitigen Regulierung des Apothekenmarktes in Deutschland: benefits and costs of current regulations in the German pharmacy sectorvon der Schulenburg, Johann-Matthias; Hodek, Jan-Marc
2016Measuring patients' priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: Methodological aspects and ranking tasksSchmidt, Katharina; Babac, Ana; Pauer, Frédéric; Damm, Kathrin; von der Schulenburg, Johann-Matthias
2018Market withdrawals' of medicines in Germany after AMNOG: A comparison of HTA ratings and clinical guideline recommendationsStaab, Thomas R.; Walter, Miriam; Mariotti Nesurini, Sonja; Dintsios, Charalabos-Markos; von der Schulenburg, Johann-Matthias; Amelung, Volker E.; Ruoff, Jörg
2019Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic reviewBabac, Ana; Damm, Kathrin; von der Schulenburg, Johann-Matthias
2020A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in GermanyBirkemeyer, Ralf; Müller, Alfred; von der Schulenburg, Johann-Matthias
2022Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countriesWahler, Steffen; Birkemeyer, Ralf; Alexopoulos, Dimitrios; Siudak, Zbigniew; Müller, Alfred; von der Schulenburg, Johann-Matthias
2022Adjuvant treatment of high-risk melanoma: Cost-effectiveness analysis of treatment options for BRAF 600 mutated tumorsWahler, Steffen; Müller, Alfred; Fuchs, Sabine; von der Schulenburg, Johann-Matthias